GBI Research

A myriad of seasoned analysts from Asia, Europe, and the U.S. is working for GBI Research where they passionately collect and interpret comprehensive industry-related business intelligence data that is delivered to many overseas companies.

The agency releases over 100 multiple reports per year for the customers across various industries. The great focus is given to the pharmaceutical and clinical sectors which GBI Research scrutinizes for such aspects as:
  • Commercial landscape
  • Pipeline products
  • Product development
  • Growth drivers
  • Key industry players
  • Market revenues on global or regional scale
  • Product and industry prospects
  • Therapeutic pharmaceutical agent
  • Market revenues, etc.
Owing to detailed and insightful market study that includes such types as primary and secondary research and in-house data analysis our specialists assist their concerned clients in making viable decisions and applying winning strategies for better business performance.

Acquired data, recommendations, and other findings are packaged in reports like:
  • Company profiles that report on company position and activity on the market supplied with demographic information.
  • Benchmarking reports where the major attention is placed on comparative analysis of financial indicators and company activities in a designated industry.
  • Market intelligence reports are destined to analyze market data, industry environment, project content overviews, and other aspects.
  • Industry outlook reports which are intended to present and interpret the experts’ vision and estimates as to the opportunities and feasibility of the company under study.

Research Reports By GBI Research

Found 148 publications
Pain Drug Development Pipeline Review, 2018 US$ 3,995.00 Sep, 2018 148 pages
Hepatitis Drug Development Pipeline Review, 2018 US$ 3,995.00 Jun, 2018 133 pages
1 2 3
Skip to top

Analytics & News by GBI Research